Cargando…

Hepatic inflammatory myofibroblastic tumor: One case report

INTRODUCTION: Hepatic inflammatory myofibroblastic tumor (HIMT) is a junctional neoplastic lesion of mesenchymal tissue origin that can sometimes become locally invasive and even metastasize or recur. Therefore, the diagnosis and treatment of HIMT is particularly important. However, hepatic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Lei, Yang, Zixuan, Ding, Ruibo, Wei, Wei, Xu, Yechuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386116/
https://www.ncbi.nlm.nih.gov/pubmed/35990088
http://dx.doi.org/10.3389/fsurg.2022.902753
_version_ 1784769730791342080
author Shen, Lei
Yang, Zixuan
Ding, Ruibo
Wei, Wei
Xu, Yechuan
author_facet Shen, Lei
Yang, Zixuan
Ding, Ruibo
Wei, Wei
Xu, Yechuan
author_sort Shen, Lei
collection PubMed
description INTRODUCTION: Hepatic inflammatory myofibroblastic tumor (HIMT) is a junctional neoplastic lesion of mesenchymal tissue origin that can sometimes become locally invasive and even metastasize or recur. Therefore, the diagnosis and treatment of HIMT is particularly important. However, hepatic inflammatory myofibroblastic tumor lacks a specific clinical presentation and typical imaging manifestations, thus posing a difficulty for us to diagnose and treat this disease. CASE PRESENTATION: We report here a very rare surgical case of hepatic inflammatory myofibroblastic tumor (HIMT) in a 41-year-old female who was admitted to the hospital for more than half a month for a liver-occupying lesion with fever found on physical examination.After discussion with the hepatobiliary and pancreatic surgery team, we decided to perform surgical treatment. The final postoperative pathology confirmed hepatitis myofibroblastoma. CONCLUSION: Our review of the domestic and international literature revealed no significant progress in the diagnosis and treatment of this disease, so we report here a case of surgical treatment. One of our aims in this case report is to highlight the efficacy of surgical treatment in HIMT. HIMT is extremely rare and difficult to diagnose. Due to their intermediate biological behavior, surgical resection should be performed whenever feasible and patients should be followed-up in order to detect recurrence and metastasis as early as possible.
format Online
Article
Text
id pubmed-9386116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93861162022-08-19 Hepatic inflammatory myofibroblastic tumor: One case report Shen, Lei Yang, Zixuan Ding, Ruibo Wei, Wei Xu, Yechuan Front Surg Surgery INTRODUCTION: Hepatic inflammatory myofibroblastic tumor (HIMT) is a junctional neoplastic lesion of mesenchymal tissue origin that can sometimes become locally invasive and even metastasize or recur. Therefore, the diagnosis and treatment of HIMT is particularly important. However, hepatic inflammatory myofibroblastic tumor lacks a specific clinical presentation and typical imaging manifestations, thus posing a difficulty for us to diagnose and treat this disease. CASE PRESENTATION: We report here a very rare surgical case of hepatic inflammatory myofibroblastic tumor (HIMT) in a 41-year-old female who was admitted to the hospital for more than half a month for a liver-occupying lesion with fever found on physical examination.After discussion with the hepatobiliary and pancreatic surgery team, we decided to perform surgical treatment. The final postoperative pathology confirmed hepatitis myofibroblastoma. CONCLUSION: Our review of the domestic and international literature revealed no significant progress in the diagnosis and treatment of this disease, so we report here a case of surgical treatment. One of our aims in this case report is to highlight the efficacy of surgical treatment in HIMT. HIMT is extremely rare and difficult to diagnose. Due to their intermediate biological behavior, surgical resection should be performed whenever feasible and patients should be followed-up in order to detect recurrence and metastasis as early as possible. Frontiers Media S.A. 2022-08-04 /pmc/articles/PMC9386116/ /pubmed/35990088 http://dx.doi.org/10.3389/fsurg.2022.902753 Text en © 2022 Shen, Yang, Ding, Wei and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Shen, Lei
Yang, Zixuan
Ding, Ruibo
Wei, Wei
Xu, Yechuan
Hepatic inflammatory myofibroblastic tumor: One case report
title Hepatic inflammatory myofibroblastic tumor: One case report
title_full Hepatic inflammatory myofibroblastic tumor: One case report
title_fullStr Hepatic inflammatory myofibroblastic tumor: One case report
title_full_unstemmed Hepatic inflammatory myofibroblastic tumor: One case report
title_short Hepatic inflammatory myofibroblastic tumor: One case report
title_sort hepatic inflammatory myofibroblastic tumor: one case report
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386116/
https://www.ncbi.nlm.nih.gov/pubmed/35990088
http://dx.doi.org/10.3389/fsurg.2022.902753
work_keys_str_mv AT shenlei hepaticinflammatorymyofibroblastictumoronecasereport
AT yangzixuan hepaticinflammatorymyofibroblastictumoronecasereport
AT dingruibo hepaticinflammatorymyofibroblastictumoronecasereport
AT weiwei hepaticinflammatorymyofibroblastictumoronecasereport
AT xuyechuan hepaticinflammatorymyofibroblastictumoronecasereport